University College, London: Lung Neoplasms trials
The registry lists 13 Lung Neoplasms studies with University College, London as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 5Phase 3 7No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Analysis of Screen-detected Lung Cancers' Genomic TraitsActive, not recruitingNCT04204499
- Electrocautery Ablation for the Prevention of Lung CancerTerminatedNCT03870152Phase 2/3
- Photodynamic Therapy for the Prevention of Lung CancerWithdrawnNCT03346304Phase 2/3
- STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)TerminatedNCT02722369Phase 2
- Lung Screen Uptake TrialCompletedNCT02558101Not applicable
- Efficacy and Safety Study of Afatinib to Treat Lung Cancer PatientsCompletedNCT01415011Phase 2
- ERCC1 Targeted TrialTerminatedNCT00801736Phase 3
- WBRT & Erlotinib in Advanced NSCLC and Brain MetastasesTerminatedNCT00554775Phase 2
- Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary DiseaseCompletedNCT00512746Not applicable
- Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung CancerCompletedNCT00433498Phase 3
- Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00309972Phase 3
- Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00275132Phase 3
- Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNCT00061919Phase 3